JP Morgan Chase’s Ardent Health ARDT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARDT
CTC
VI
GAM
CM
BCM
JP Morgan Chase's ARDT Position: Q2 2026 in Review
JP Morgan Chase increased its Ardent Health (ARDT) stake by 44% in Q2 2026, buying an estimated $699K and bringing the position to 242,329 shares worth $2.41M. The position accounts for ﹤0.01% of the portfolio, ranked #4060.
JP Morgan Chase first reported a position in ARDT in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.68M in Q2 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.
- JP Morgan Chase held 242,329 shares of Ardent Health worth $2.41M as of Q2 2026.
- JP Morgan Chase bought 73,721 Ardent Health shares in Q2 2026, an estimated $699K.
- Ardent Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4060 holding.
- JP Morgan Chase first reported a position in Ardent Health in Q3 2024 and has held it in 8 quarters since.
- JP Morgan Chase's Ardent Health position peaked at $4.68M in Q2 2025.
- 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.